1. Academic Validation
  2. Escape from TGF-β-induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

Escape from TGF-β-induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

  • Mol Oncol. 2025 Mar 14. doi: 10.1002/1878-0261.70021.
Minenur Kalyoncu 1 Dilara Demirci 1 Sude Eris 1 2 Bengisu Dayanc 1 2 Ece Cakiroglu 1 2 Merve Basol 1 2 Merve Uysal 1 2 Gulcin Cakan-Akdogan 1 3 Fang Liu 4 Mehmet Ozturk 5 6 Gökhan Karakülah 1 2 Serif Senturk 1 2 6
Affiliations

Affiliations

  • 1 Izmir Biomedicine and Genome Center, Turkey.
  • 2 Department of Genomics and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.
  • 3 Department of Biomedicine and Health Technologies, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.
  • 4 Center for Advanced Biotechnology and Medicine, Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
  • 5 Department of Medical Biology, Izmir Tinaztepe University School of Medicine, Turkey.
  • 6 Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Abstract

Transforming growth factor-β (TGF-β) signaling and cellular senescence are key hallmarks of hepatocellular carcinoma (HCC) pathogenesis. Despite provoking senescence-associated growth arrest in epithelial HCC cells, elevated TGF-β activity paradoxically correlates with increased aggressiveness and poor prognosis in advanced tumors. Whether the transition between these dichotomous functions involves modulation of the senescence phenotype during disease progression remains elusive. Exploiting the epithelial HCC cell line Huh7 as a robust model, we demonstrate that chronic exposure to TGF-β prompts escape from Smad3-mediated senescence, leading to the development of TGF-β resistance. This altered state is characterized by an optimal proliferation rate and the acquisition of molecular and functional traits of less-differentiated mesenchymal cells, coinciding with differential growth capacity in 2D and 3D culture conditions, epithelial-to-mesenchymal transition (EMT), and increased invasiveness in vitro, and metastasis in vivo. Mechanistically, resistant cells exhibit defective activation and nuclear trafficking of Smad molecules, particularly SMAD3, as ectopic activation of the TGF-β/SMAD3 axis is able to reinstate TGF-β sensitivity. An integrated transcriptomic landscape reveals both shared and distinct gene signatures associated with senescent and TGF-β resistant states. Importantly, genetic ablation and molecular studies identify microtubule affinity regulating kinase 1 (MARK1) and glutamate metabotropic receptor 8 (GRM8) as critical modulators of the resistance phenomenon, potentially by impairing spatiotemporal signaling dynamics of Smad activity. Our findings unveil a novel phenomenon wherein epithelial HCC cells may exploit senescence plasticity as a mechanism to oppose TGF-β anti-tumor responses and progress towards more aggressive HCC phenotypes.

Keywords

EMT; TGF‐β; hepatocellular carcinoma; resistance; senescence escape.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-126839
    99.84%, β-Galactosidase Fluorescent Substrate